Literature DB >> 11132108

The effect of oxidatively modified low-density lipoproteins on platelet aggregability and membrane fluidity.

I I Vlasova1.   

Abstract

The influence of oxidised low-density lipoproteins (oxLDL) on blood cell functions plays a role in the progression of atherosclerosis. In the present work the effects of mildly oxidised LDL (moxLDL) on platelet aggregability and plasma membrane fluidity were studied and analysed from the viewpoint of the extent of LDL oxidation. Native or oxidised LDL were incubated with platelet rich plasma (PRP) at the volume ratio 1:1. As a control, plasma was incubated with buffer. The effects on ADP-induced platelet aggregation and certain membrane characteristics are described. (1) Mildly oxidised LDL diminished the time-dependent decrease in platelet aggregability that was observed when PRP was incubated with buffer or native LDL. The higher the oxidation extent of moxLDL, the lesser (if any) decrease in platelet activity occurred. Therefore moxLDL activated platelets in PRP. Cu2+-oxidised LDL, characterised by a high extent of lipid oxidation, inhibited ADP-induced platelet aggregation. (2) Comparison of the ESR spectra of spin-labelled fatty acid (5-doxylstearate) incorporated into the plasma membrane of washed platelets indicated that the presence of moxLDL in the incubation medium resulted in a reduced fluidity of the outer membrane layer. The cholesterol:phospholipid ratio in platelets appeared to be the same after PRP incubation with native LDL, moxLDL or buffer. It may be proposed that the binding of oxLDL to the platelet surface leads to a modification of the membrane fluidity, thus mediating the activating action of LDL on platelets. Both effects were proportional to the extent of lipid oxidation in LDL. The results of this paper indicate a crucial role for mildly oxidised LDL in platelet activation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11132108     DOI: 10.1080/09537100020000157

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  5 in total

1.  Low concentration of oxidized low density lipoprotein suppresses platelet reactivity in vitro: an intracellular study.

Authors:  Duen-Suey Chou; George Hsiao; Ming-Yi Shen; Tsorng-Harn Fong; Chien-Huang Lin; Tzeng-Fu Chen; Joen-Rong Sheu
Journal:  Lipids       Date:  2004-05       Impact factor: 1.880

2.  Hostility and platelet reactivity in individuals without a history of cardiovascular disease events.

Authors:  Daichi Shimbo; William Chaplin; Sujith Kuruvilla; Lauren Taggart Wasson; Dennis Abraham; Matthew M Burg
Journal:  Psychosom Med       Date:  2009-07-10       Impact factor: 4.312

3.  Ezetimibe's effect on platelet aggregation and LDL tendency to peroxidation in hypercholesterolaemia as monotherapy or in addition to simvastatin.

Authors:  Osamah Hussein; Lilia Minasian; Yaroslav Itzkovich; Karina Shestatski; Lizora Solomon; Jamal Zidan
Journal:  Br J Clin Pharmacol       Date:  2008-01-30       Impact factor: 4.335

4.  Cultured cells of the blood-brain barrier from apolipoprotein B-100 transgenic mice: effects of oxidized low-density lipoprotein treatment.

Authors:  Nikolett Lénárt; Fruzsina R Walter; Alexandra Bocsik; Petra Sántha; Melinda E Tóth; András Harazin; Andrea E Tóth; Csaba Vizler; Zsolt Török; Ana-Maria Pilbat; László Vígh; László G Puskás; Miklós Sántha; Mária A Deli
Journal:  Fluids Barriers CNS       Date:  2015-07-17

5.  Effect of statins on platelet function in patients with hyperlipidemia.

Authors:  Joanna Sikora; Barbara Kostka; Iwona Marczyk; Urszula Krajewska; Maciej Chałubiński; Marlena Broncel
Journal:  Arch Med Sci       Date:  2013-08-08       Impact factor: 3.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.